ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Vanguard Communication Services ETF

Vanguard Communication Services ETF (VOX)

159.12
-0.42
(-0.26%)
종가: 06 12월 6:00AM
159.12
0.00
( 0.00% )
시간외 거래: 6:15AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
159.12
매수가
-
매도가
-
거래량
55,856
159.00 일간 변동폭 160.35
110.265 52주 범위 159.83
market_cap
전일 종가
159.54
개장가
160.07
최근 거래 시간
159
@
159.12
마지막 거래 시간
08:30:00
재정 규모
US$ 8,913,901
VWAP
159.5872
평균 볼륨(3m)
92,250
발행 주식
28,656,000
배당수익률
-
주가수익률
4.68
주당순이익(EPS)
33.99
매출
47.39M
순이익
974.02M

Vanguard Communication Services ETF 정보

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Communication Services 25/50, an index made up of stocks of large, mid-size, and small U.S. companies wi... The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Communication Services 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the communication services sector, as classified under the GICS. The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified. 더 보기

섹터
Mgmt Invt Offices, Open-end
산업
Mgmt Invt Offices, Open-end
웹사이트
본부
Valley Forge, Pennsylvania, USA
설립됨
-
Vanguard Communication Services ETF is listed in the Mgmt Invt Offices, Open-end sector of the 아메리카 증권거래소 with ticker VOX. The last closing price for Vanguard Communication S... was US$159.54. Over the last year, Vanguard Communication S... shares have traded in a share price range of US$ 110.265 to US$ 159.83.

Vanguard Communication S... currently has 28,656,000 shares in issue. The market capitalisation of Vanguard Communication S... is US$4.57 billion. Vanguard Communication S... has a price to earnings ratio (PE ratio) of 4.68.

VOX 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
14.482.89705121573154.64159.83154.64105711158.1300398SP
45.273.42541436464153.85159.83150.4485595155.06238068SP
1222.9916.8882685668136.13159.83136.11592250148.48630697SP
2623.3117.1636845593135.81159.83127.35112261141.36253958SP
5248.0243.2223222322111.1159.83110.265142035132.05276677SP
15627.0920.5180640763132.03159.8378.25226553107.67811398SP
26067.2873.257839721391.84159.8366.51220391108.63747883SP

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ZBAOZhibao Technology Inc
US$ 6.25
(145.10%)
2.2M
PGHLPrimega Group Holdings Ltd
US$ 1.83
(37.08%)
4.16M
GXAIGaxos ai Inc
US$ 1.83
(28.87%)
1.19M
HCTIHealthcare Triangle Inc
US$ 0.80
(15.62%)
1.47k
CDIOCardio Diagnostics Holdings Inc
US$ 0.5364
(15.50%)
10.19M
ORISOriental Rise Holdings Ltd
US$ 10.9365
(-80.47%)
3.57M
ENGENGlobal Corp
US$ 0.6409
(-40.66%)
77.06k
CAMPCAMP4 Therapeutics Corporation
US$ 7.65
(-22.02%)
68.03k
BOCNUBlue Ocean Acquisition Corporation
US$ 9.23
(-18.03%)
100
ZCMDZhongchao Inc
US$ 1.20
(-16.08%)
4.26k
SVMHSRIVARU Holding Ltd
US$ 0.038
(8.57%)
11.91M
CDIOCardio Diagnostics Holdings Inc
US$ 0.5364
(15.50%)
10.19M
SMCISuper Micro Computer Inc
US$ 41.25
(0.27%)
7.06M
XTIAXTI Aerospace Inc
US$ 0.0449
(-1.32%)
5.5M
SOUNSoundHound AI Inc
US$ 14.1376
(6.06%)
4.27M
band aid band aid 4 분 전
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 4 분 전
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 4 분 전
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 4 분 전
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 4 분 전
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 5 분 전
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 5 분 전
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ
Richard H2 Richard H2 6 분 전
Just in:

http://www.nashvillechanceryinfo.org/CaseDetail.aspx?CaseID=80738

IN THE CHANCERY COURT FOR THE STATE OF TENNESSEE
TWENTIETH JUDICIAL DISTRICT, DAVIDSON COUNTY – CASE No.23-1020-II

B&K ENERGY, LLC – Plaintiff
v
HOLCOMB ENE
BKH
Dr Quest Dr Quest 6 분 전
"Existing management has already for two years overstated the value of the Company by advancing the ~$10.00 per share NAV narrative. "

So with the current offer by Ready, the merger price comes in at 5.50+/share. That would be a erosion of value of 45% over two years. Over those same
MartinLutherKing MartinLutherKing 7 분 전
3.TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
August 15 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced initiation of its Pha
RNAZ
Gamco Gamco 8 분 전
style="font-size: 16px"From Gemini:
style="font-size: 16px"

style="font-size: 16px"The potential implications of Tesla's appeal for a UK global FRAND rate ruling against Avanci/InterDigital are significant and could reshape the landscape of patent licensing in the t
IDCC
Zorch305 Zorch305 8 분 전
Lots of goodluck with Multiple irons in the fire!!
RDAR
Dragonman1 Dragonman1 8 분 전
I never said I was looking at this Co For a pump and dump your a liar!
KEGS
northam43 northam43 8 분 전
Report #6 SPX All Cycles Chart.

https://investorshub.advfn.com/uimage/uploads/2024/12/5/kxaxx6_All_Cycles_Chart.png
MartinLutherKing MartinLutherKing 8 분 전
2. TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
May 29 2024 - 9:15AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer
RNAZ
No-Quarter No-Quarter 9 분 전
That's a new one for me. Added. Thx
PickStocks PickStocks 9 분 전
Quote: " style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-family: Nunito, serif; background-color: rgba(255, 255, 255, 1); font-size: 1em"Chad and Doreen can’t tell you, I, or AZ anything."
style="caret-color: rgb(33, 37, 41); color: rgba(33, 37, 41, 1); font-fami
COOP
nowwhat2 nowwhat2 9 분 전
Oh no......Not again !

https://investorshub.advfn.com/uimage/uploads/2024/12/5/vxyosxrp_121212_5_hyper_CAPT_not_again.jpg



FOMO
XRPUSD
arizona1 arizona1 9 분 전
I absolutely can understand why the UHC president was murdered.

I don’t like that it happened, but I can understand why people would want him dead, given the reports of UHC denying coverage to patients, which in this day and age, can mean that those patients die for lack of treatment.
MartinLutherKing MartinLutherKing 10 분 전
1. TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15 2024 - 9:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cance
RNAZ
fwb fwb 12 분 전
NVDA will SUPPLY the HARDWARE (CHIPS)
The computers will be built by others.
PLTR will be one of the SOFTWARE Companies those Computers will run on that will help the companies using them to improve on efficiency
It's how all these companies will USE these products for their bus
NVDA PLTR
BeepBeepMF BeepBeepMF 13 분 전
that chart ❤️ what a beaut it is $RDAR
RDAR

최근 히스토리

Delayed Upgrade Clock